Reclaiming Brand Loyalty in the Generic Era

A Strategic Approach to Mitigating Brand Attrition Through White Label Pharmacy Solutions

For many leading pharmaceutical brands, even those with strong HCP loyalty and established efficacy, the loss of exclusivity leading to an introduction of a generic equivalent marks a turning point. Payer formularies and pharmacies often shift to favor the lower-cost generic.

This creates a significant challenge for HCPs. While they may prefer prescribing the brand, the reality of insurance barriers and pharmacy economics forces their hand. To ensure their patients receive timely and affordable treatment, they often default to prescribing the generic substitution. Consequently, the manufacturer loses a loyal patient and prescriber

The Challenge: Generic substitution driven by inadequate coverage, brand awareness or limited accessibility to the product

Explore the Market Dynamics Driving Generic Substitution

Payer Barriers: PBM’s actively steer patients toward lower-cost generics to manage their own expenditures

Pharmacy Switching: Pharmacies actively switch patients from brand to generic to improve their financials.

HCP Burden: HCP Burden: Complex prior authorization and step therapy processes for branded drugs consume valuable administrative time for prescribers.

Patient Affordability: Patient Affordability:Without adequate coverage, the out-of-pocket cost for branded prescriptions can be prohibitive for patients, leaving generics as the only viable option.

Erosion of Brand Loyalty: Continuous prescription of generics can diminish long-term brand recognition and
loyalty among both patients and the next generation of HCPs.

The Solution: CareTria’s White Label Pharmacy Program

To create a way to reduce brand attrition, manufacturers require a more direct solution that bypasses the complexities of a traditional PBM process and high abandonment seen in retail pharmacies. CareTria’s white label pharmacy program provides a direct, manufacturer-sponsored pathway for patients to access branded
medications at a highly aordable price while protecting gross-to-net.

This model establishes a dedicated, branded pharmacy that acts as a seamless extension of the manufacturer. This approach dramatically simplifies the prescribing process for HCPs while providing a consistent and reliable access channel with dispensing turnaround time of approximately one day.

Core Components of the White Label Pharmacy (WLP) Solution

• Engaging providers to generate prescription demand: CareTria can help generate prescription demand through its provider engagement engine which includes a combination of literature, samples and inside sales that are specific to your brand to create awareness and demand for prescriptions pointed to the white label pharmacy. If used, samples can additionally carry a QR code connecting the patient with the white label pharmacy program
• Real-time adherence analytics: All prescriptions and patient engagements are managed through a single customized, fully branded, white label pharmacy and engagement portal giving the manufacturer clear insights into the obstacles of patients starting new prescriptions and existing patients staying on therapy.
• Faster order to therapy: Prescriptions are processed, dispensed, and shipped directly to the patient from a highly automated and scalable pharmacy, ensuring a 1-2 day turn around time from prescription written to drug in patient’s possession.
• Improved adherence and compliance: Introduction of auto-refills and omni-channel adherence programs drives more total fills per patients improving program performance and patient compliance.

Conclusion: A Strategic Imperative for Brand Longevity

In an environment where payer restrictions and pharmacy economics often override clinical preference,
pharmaceutical manufacturers must adopt innovative strategies to maintain market leadership.
Relying solely on traditional market access and distribution channels leaves brands vulnerable to
generic substitution and revenue loss.

CareTria’s white label pharmacy solution oers a proven, powerful alternative. By providing a branded,
direct, aordable, and seamless cash-pay channel, manufacturers can empower HCPs to prescribe the
brand they trust and enable patients to access the therapy they prefer. This model transforms a significant
market challenge into a strategic opportunity, securing brand loyalty and driving sustainable revenue
growth for years to come.

Don’t let generics erode your market share — explore CareTria’s white label pharmacy solutions today.